|
ZFP37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.418900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.513400E-01 |
| Normal-vs-Stage2 |
9.860200E-03 |
| Normal-vs-Stage3 |
1.09719999996649E-06 |
| Normal-vs-Stage4 |
2.89650003981734E-09 |
| Stage1-vs-Stage2 |
1.515910E-02 |
| Stage1-vs-Stage3 |
2.14040000001692E-06 |
| Stage1-vs-Stage4 |
4.82829998205148E-09 |
| Stage2-vs-Stage3 |
7.582400E-01 |
| Stage2-vs-Stage4 |
1.856190E-01 |
| Stage3-vs-Stage4 |
8.033700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.419400E-04 |
| Normal-vs-AfricanAmerican |
1.641040E-01 |
| Normal-vs-Asian |
6.839400E-01 |
| Caucasian-vs-AfricanAmerican |
4.366800E-01 |
| Caucasian-vs-Asian |
4.774400E-01 |
| AfricanAmerican-vs-Asian |
7.450200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.035000E-04 |
| Normal-vs-Female |
2.977600E-03 |
| Male-vs-Female |
8.074600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.515900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.263900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.21259999999757E-05 |
| Normal-vs-Age(81-100Yrs) |
3.702300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.353200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.428000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.334600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.978000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.127800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.461580E-01 |
| Normal-vs-Grade 2 |
6.461000E-01 |
| Normal-vs-Grade 3 |
1.52379999995844E-06 |
| Normal-vs-Grade 4 |
1.34730004930361E-11 |
| Grade 1-vs-Grade 2 |
2.341400E-01 |
| Grade 1-vs-Grade 3 |
2.841200E-04 |
| Grade 1-vs-Grade 4 |
4.6460000002746E-07 |
| Grade 2-vs-Grade 3 |
5.09910000001668E-07 |
| Grade 2-vs-Grade 4 |
8.19966317067156E-12 |
| Grade 3-vs-Grade 4 |
8.588200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.986400E-01 |
| Normal-vs-ccB subtype |
8.01590016585862E-10 |
| ccA subtype-vs-ccB subtype |
4.7706283368143E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.205000E-04 |
| Normal-vs-N1 |
1.55629999998297E-06 |
| N0-vs-N1 |
6.419900E-03 |
|
|
